1. Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and parallel‐group study. (1st December 2022) Authors: Landis, Megan N.; Arya, Mark; Smith, Stacy; Draelos, Zoe; Usdan, Lisa; Tarabar, Sanela; Pradhan, Vivek; Aggarwal, Sudeepta; Banfield, Christopher; Peeva, Elena; Vincent, Michael S.; Sikirica, Vanja; Xenakis, Jason; Beebe, Jean S. Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and parallel‐group study. (23rd October 2022) Authors: Landis, Megan N.; Arya, Mark; Smith, Stacy; Draelos, Zoe; Usdan, Lisa; Tarabar, Sanela; Pradhan, Vivek; Aggarwal, Sudeepta; Banfield, Christopher; Peeva, Elena; Vincent, Michael S.; Sikirica, Vanja; Xenakis, Jason; Beebe, Jean S. Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib. Issue 1 (11th October 2021) Authors: Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Silverberg, Jonathan I.; Papacharalambous, Jocelyne; Zhu, Linda; Zhang, Weidong; Beebe, Jean S.; Vincent, Michael; Peeva, Elena; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Chen, Linda; Sikirica, Vanja; Xenakis, Jason Journal: Dermatitis Issue: Volume 32:Issue 1S(2021) Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib. Issue 1 (October 2021) Authors: Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Silverberg, Jonathan I.; Papacharalambous, Jocelyne; Zhu, Linda; Zhang, Weidong; Beebe, Jean S.; Vincent, Michael; Peeva, Elena; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Chen, Linda; Sikirica, Vanja; Xenakis, Jason Journal: Dermatitis Issue: Volume 32:Issue 1S(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Technology and social media use by adult patients with intellectual and/or developmental disabilities. Issue 1 (January 2020) Authors: Patrick, Patricia A.; Obermeyer, Izel; Xenakis, Jason; Crocitto, Doug; O'Hara, David M. Journal: Disability and health journal Issue: Volume 13:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗